DERM — Journey Medical Income Statement
0.000.00%
Last trade - 00:00
- $109.27m
- $102.90m
- $79.18m
- 73
- 27
- 81
- 63
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 34.9 | 44.5 | 63.1 | 73.7 | 79.2 |
Cost of Revenue | |||||
Gross Profit | 24.4 | 29.9 | 31.1 | 42.9 | 52.5 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 29.7 | 36.7 | 98 | 101 | 81.3 |
Operating Profit | 5.26 | 7.85 | -34.9 | -27.5 | -2.07 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 5 | 7.15 | -42.4 | -29.6 | -3.63 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3.63 | 5.28 | -44 | -29.6 | -3.85 |
Net Income Before Extraordinary Items | |||||
Net Income | 3.63 | 5.28 | -44 | -29.6 | -3.85 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 3.63 | 5.28 | -44 | -29.6 | -3.85 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.22 | 0.321 | -4.32 | -1.68 | -0.099 |
Dividends per Share |